levosalbutamol also known levalbuterol shortacting adrenergic receptor agonist used treatment asthma chronic obstructive pulmonary disease copd evidence inconclusive regarding efficacy levosalbutamol versus salbutamol salbutamollevosalbutamol combinations though levosalbutamol believed better safety profile due selective binding receptors primarily lungs versus primarily heart drug prototype drug salbutamol available countries generic formulations pharmaceutical companies including cipla teva dey among others levosalbutamols bronchodilator properties give indications treatment copd chronic obstructive pulmonary disease also known chronic obstructive lung disease asthma like bronchodilators acts relaxing smooth muscle bronchial tubes thus shortening reversing acute attack shortness breath difficulty breathing unlike sloweracting bronchodilators indicated preventative chronic bronchial constriction systematic review drugs use treatment acute asthma found superior albuterol regarding efficacy safety subjects acute asthma review concluded suggest levalbuterol used albuterol acute levalbuterol notably generally levosalbutamol well tolerated common mild sideeffects include elevated heart rate muscle cramps gastric upset including heartburn symptoms overdose particular include collapse seizure chest pain possible precursor heart attack fast pounding heartbeat may cause raised blood pressure hypertension irregular heartbeat cardiac arrhythmia may cause paradoxical lowered blood pressure hypotension nervousness tremor headache dizziness nauseavomiting weakness exhaustion medical fatigue dry mouth rarer side effects may indicate dangerous allergic reaction include paradoxical bronchospasm shortness breath difficulty breathing skin itching rash hives urticaria swelling angioedema part face throat lead voice hoarseness swelling activation adrenergic receptors airway smooth muscle leads activation adenylate cyclase increase intracellular concentration adenosine monophosphate cyclic amp increase cyclic amp associated activation protein kinase turn inhibits phosphorylation myosin lowers intracellular ionic calcium concentrations resulting muscle relaxation levosalbutamol relaxes smooth muscles airways trachea terminal bronchioles increased cyclic amp concentrations also associated inhibition release mediators mast cells airways levosalbutamol acts functional agonist relaxes airway irrespective spasmogen involved thereby protecting bronchoconstrictor challenges recognized adrenergic receptors predominant receptors bronchial smooth muscle data indicate beta receptors human heart adrenergic receptors precise function receptors established however Î² adrenergic agonist drugs produce significant cardiovascular effect patients measured pulse rate blood pressure restlessness symptoms andor electrocardiographic ecg levosalbutamol inn levalbuterol usan levalbuterol approved united states solution used nebulizer device march march became available formulation metereddose inhaler trade name xopenex hfa levalbuterol tartrate inhalation stimulants phenylethanolamine httpsenwikipediaorgwikilevosalbutamol